The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients
Abstract
Bleomycin, a mixture of antibiotic polypeptides, was evaluated for therapeutic activity and clinical toxicology in 274 patients with far-advanced, nonresectable neoplastic disease. Therapeutic effect was most marked in advanced Hodgkin's disease, in which 50% of patients had significant objective and subjective improvement, in some cases for periods now approaching 2 years. Scattered responses of brief duration were seen in other neoplastic diseases. The clinical toxicity of bleomycin appears to be unique among antitumor agents; it produces no important effects on the blood-forming organs, gastrointestinal tract, liver, kidneys, or central nervous system. Pulmonary functional impairment, however, is common; irreversible pulmonary fibrosis, although rare, is a serious, sometimes lethal, manifestation of bleomycin toxicity that may limit its use in early neoplastic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TRANSAMINASE ACTIVITY IN HUMAN BLOOD
Karmen, A., Wróblewski, F., & LaDue, J. S. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103055 · Cited by 1,708
Quantitative Determination of Serum Immunoglobulins in Antibody-Agar Plates
Fahey, J. L., & McKelvey, E. M. (1965) · The Journal of Immunology · doi:10.4049/jimmunol.94.1.84 · Cited by 1,528
Langdell, R. D., Wagner, R. H., & Brinkhous, K. M. (1953) · PubMed · Cited by 736
New antibiotics, bleomycin A and B.
Umezawa, H., Maeda, K., Takeuchi, T., & Okami, Y. (1966) · PubMed · Cited by 725
Filley, G. F., MacIntosh, D. J., & Wright, G. W. (1954) · Journal of Clinical Investigation · doi:10.1172/jci102923 · Cited by 348
STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*
Sherry, S., Lindemeyer, R. I., Fletcher, A. P., & Alkjaersig, N. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103863 · Cited by 280
Umezawa, H., Ishizuka, M., Maeda, K., & Takeuchi, T. (1967) · Cancer · doi:10.1002/1097-0142(1967)20:5<891::aid-cncr2820200550>3.0.co;2-v · Cited by 189
MECHANISM OF ACTION OF BLEOMYCIN. STUDIES WITH THE GROWING CULTURE OF BACTERIAL AND TUMOR CELLS
SUZUKI, H., NAGAI, K., YAMAKI, H., TANAKA, N., & UMEZAWA, H. (1968) · The Journal of Antibiotics · doi:10.7164/antibiotics.21.379 · Cited by 184
Bleomycin Treatment of the Tumors of Penis and Scrotum
Ichikawa, T., Nakano, I., & 広川, 勲. (1969) · The Journal of Urology · doi:10.1016/s0022-5347(17)62235-3 · Cited by 128
Cited by
Sleijfer, S. (2001) · Chest · doi:10.1378/chest.120.2.617 · Cited by 611
The Bleomycin Model of Pulmonary Fibrosis
Liu, T., De Los Santos, F. G., & Phan, S. H. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7113-8_2 · Cited by 357
Modeling pulmonary fibrosis with bleomycin
Mouratis, M. A., & Aidinis, V. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328349ac2b · Cited by 311
Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular Cancer
VOGELZANG, N. J., BOSL, G. J., JOHNSON, K., & KENNEDY, B. J. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-3-288 · Cited by 296
Bleomycin-Induced Pulmonary Toxicity
Jules-Elysee, K., & White, D. A. (1990) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(21)00668-7 · Cited by 253
Metadata
- Authors
- YAGODA, A., MUKHERJI, B., YOUNG, C., ETCUBANAS, E., LAMONTE, C., SMITH, J. R., TAN, C. T. C., & KRAKOFF, I. H.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1972-12-01
- Volume
- 77
- Issue
- 6
- Pages
- 861-870
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2012740157
- Cited by
- 286
- References
- 9
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients. https://app.cochat.ai/papers/10.7326/0003-4819-77-6-861
- The paper
- YAGODA, A., MUKHERJI, B., YOUNG, C., ETCUBANAS, E., LAMONTE, C., SMITH, J. R., TAN, C. T. C., & KRAKOFF, I. H. (1972). Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-77-6-861
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.